EU regulators approved the Pfizer-BioNTech coronavirus vaccine yesterday, authorizing the drug for its 448M inhabitants (across its 27 member states). The greenlight follows earlier approval in the UK and the US, where distribution has already started. Distribution in some EU states could start as early as Sunday.
Extra: The EU has ordered 300M doses of the vaccine, enough for 150M people given the Pfizer-BioNTech vaccine requires two doses.
The New Paper
This story is from the December 22, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.